Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Griffin

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Gastroenterology|November 16, 2005
Unexpected role of surface transglutaminase type II in celiac diseaseLuigi Maiuri, Carolina Ciacci, Ida Ricciardelli, et al.
Chemistry & Biology|October 13, 2015
Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological ConditionsEduard Badarau, Zhuo Wang, Dan L Rathbone, et al.
BMJ Open Sport & Exercise Medicine|March 15, 2023
Fidelity and tolerability of two high-intensity interval training protocols in patients with COPD: a randomised cross-over pilot studyStine Buus Nymand, Jacob Hartmann, Iben Elmerdahl Rasmussen, et al.
Transplantation|June 18, 2004
Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy?Timothy S Johnson, Hamdy Abo-Zenah, James N Skill, et al.
The British Journal of Ophthalmology|May 8, 2010
The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticlesDavid Y S Chau, Naing L Tint, Russell J Collighan, et al.
Journal of Clinical Immunology|August 11, 2012
Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept studyTiina Rauhavirta, Mikko Oittinen, Rami Kivistö, et al.
Amino Acids|December 25, 2009
Thermodynamics of binding of regulatory ligands to tissue transglutaminaseCarlo M Bergamini, Alessia Dondi, Vincenzo Lanzara, et al.
Journal of Neurochemistry|June 18, 2002
Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stressMauro Piacentini, Maria Grazia Farrace, Lucia Piredda, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
Tissue transglutaminase and the progression of human renal scarringTimothy S Johnson, Ahmed F El-Koraie, N James Skill, et al.
Cellular and Molecular Life Sciences : CMLS|August 15, 2009
Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoAEssi Myrsky, Sergio Caja, Zsofi Simon-Vecsei, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Gastroenterology|November 16, 2005
Unexpected role of surface transglutaminase type II in celiac diseaseLuigi Maiuri, Carolina Ciacci, Ida Ricciardelli, et al.
Chemistry & Biology|October 13, 2015
Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological ConditionsEduard Badarau, Zhuo Wang, Dan L Rathbone, et al.
BMJ Open Sport & Exercise Medicine|March 15, 2023
Fidelity and tolerability of two high-intensity interval training protocols in patients with COPD: a randomised cross-over pilot studyStine Buus Nymand, Jacob Hartmann, Iben Elmerdahl Rasmussen, et al.
Transplantation|June 18, 2004
Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy?Timothy S Johnson, Hamdy Abo-Zenah, James N Skill, et al.
The British Journal of Ophthalmology|May 8, 2010
The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticlesDavid Y S Chau, Naing L Tint, Russell J Collighan, et al.
Journal of Clinical Immunology|August 11, 2012
Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept studyTiina Rauhavirta, Mikko Oittinen, Rami Kivistö, et al.
Amino Acids|December 25, 2009
Thermodynamics of binding of regulatory ligands to tissue transglutaminaseCarlo M Bergamini, Alessia Dondi, Vincenzo Lanzara, et al.
Journal of Neurochemistry|June 18, 2002
Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stressMauro Piacentini, Maria Grazia Farrace, Lucia Piredda, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
Tissue transglutaminase and the progression of human renal scarringTimothy S Johnson, Ahmed F El-Koraie, N James Skill, et al.
Cellular and Molecular Life Sciences : CMLS|August 15, 2009
Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoAEssi Myrsky, Sergio Caja, Zsofi Simon-Vecsei, et al.
Pageof 8